Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers

VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE

Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,925 · see citing works

Psychopharmacology: The third generation of progress

O’Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,020 · see citing works

Wechsler Adult Intelligence Scale--Third Edition

Wechsler, D. (2019) · PsycTESTS Dataset · doi:10.1037/t49755-000 · Cited by 2,327 · see citing works

Psychopharmacology: The Third Generation of Progress.

(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,021 · see citing works

Structured Clinical Interview for DSM-III-R Personality Disorders

First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2012) · PsycTESTS Dataset · doi:10.1037/t07827-000 · Cited by 1,403 · see citing works

Cambridge Neuropsychological Test Automated Battery (CANTAB): A Factor Analytic Study of a Large Sample of Normal Elderly Volunteers

Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., McInnes, L., & Rabbitt, P. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106735 · Cited by 1,078 · see citing works

Untitled work

(2001) · Medical Entomology and Zoology · Cited by 1,044 · see citing works

Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers

Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Leonido–Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., HITZEMANN, R. J., Ding, Y. ‐., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984 · see citing works

Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine

Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W. W., & London, E. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 760 · see citing works

Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence

Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Miller, E. N., HITZEMANN, R. J., Ding, Y., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754 · see citing works

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G. D., Anthony, R. M., Schmunk, G. A., Shannak, K. S., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718 · see citing works

A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: Implications for theories of executive functioning and cognitive aging

Robbins, T. W., James-Galton, M., Owen, A. M., Sahakian, B. J., Lawrence, A. D., McInnes, L., & Rabbitt, P. (1998) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617798455073 · Cited by 607 · see citing works

Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [¹¹C]WIN-35,428

McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602 · see citing works

Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity

(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1652 · Cited by 528 · see citing works

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

Wagner, G. C., Ricaurte, G. A., Seiden, L. S., Schuster, C. R., Miller, R. J., & Westley, J. (1980) · Brain Research · doi:10.1016/0006-8993(80)91265-2 · Cited by 523 · see citing works

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90198-6 · Cited by 479 · see citing works

Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.

Hotchkiss, A. J., & Gibb, J. W. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32165-8 · Cited by 443 · see citing works

Profiles of Cognitive Dysfunction in Chronic Amphetamine and Heroin Abusers

Ornstein, T. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00097-x · Cited by 429 · see citing works

Clinical Neuropsychology

Kløve, H. (1963) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)33515-5 · Cited by 411 · see citing works

Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET

Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Takei, N., & Mori, N. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1206 · Cited by 408 · see citing works

Magnetic Resonance Spectroscopy

Gujar, S. K., Maheshwari, S., Bj??rkman-Burtscher, I., & Sundgren, P. C. (2005) · Journal of Neuro-Ophthalmology · doi:10.1097/01.wno.0000177307.21081.81 · Cited by 380 · see citing works

Evidence for long-term neurotoxicity associated with methamphetamine abuse

Ernst, T., Chang, L., Leonido–Yee, M., & Speck, O. (2000) · Neurology · doi:10.1212/wnl.54.6.1344 · Cited by 373 · see citing works

California Verbal Learning Test--Second Edition

Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (1987) · PsycTESTS Dataset · doi:10.1037/t15072-000 · Cited by 347 · see citing works

Cognitive Impairment in Individuals Currently Using Methamphetamine

Simon, S. L., Domier, C. P., Carnell, J., Brethen, P., Rawson, R. A., & Ling, W. W. (2000) · American Journal on Addictions · doi:10.1080/10550490050148053 · Cited by 322 · see citing works

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys

Seiden, L. S., Fischman, M. W., & Schuster, C. R. (1976) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(76)90030-2 · Cited by 307 · see citing works

Methamphetamine Dependence Is Associated With Neurocognitive Impairment in the Initial Phases of Abstinence

Kalechstein, A. D., Newton, T. F., & Green, M. M. (2003) · Journal of Neuropsychiatry · doi:10.1176/jnp.15.2.215 · Cited by 288 · see citing works

Positron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson Disease

Bohnen, N. I., Albin, R. L., Koeppe, R. A., Wernette, K., Kilbourn, M. R., Minoshima, S., & Frey, K. A. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600276 · Cited by 254 · see citing works

Association of Dopamine Transporter Loss in the Orbitofrontal and Dorsolateral Prefrontal Cortices With Methamphetamine-Related Psychiatric Symptoms

Sekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K., Suzuki, K., Tsukada, H., Okada, H., Yoshikawa, E., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1699 · Cited by 242 · see citing works

Cognitive Performance of Current Methamphetamine and Cocaine Abusers

Simon, S. L., Domier, C. P., Sim, T., Richardson, K., Rawson, R. A., & Ling, W. W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_06 · Cited by 228 · see citing works

Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users

Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido–Yee, M., & Miller, E. N. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00004-5 · Cited by 224 · see citing works

Western psychological services

Madden, S. (1996) · Journal of Adolescent Health · doi:10.1016/s1054-139x(96)00178-4 · Cited by 207 · see citing works

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments

Borght, T. V., Kilbourn, M. R., Desmond, T. J., Kuhl, D. E., & Frey, K. A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00594-3 · Cited by 205 · see citing works

Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals

Salo, R. E., NORDAHL, T. E., Possin, K. L., Leamon, M. H., Gibson, D. R., Galloway, G. P., Flynn, N. M., Henik, A., Pfefferbaum, A., & Sullivan, E. V. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00111-7 · Cited by 187 · see citing works

Why is parkinsonism not a feature of human methamphetamine users?

Moszczyńska, A., Fitzmaurice, P. S., Ang, L. C., Kalasinsky, K. S., Schmunk, G. A., Peretti, F. J., Aiken, S. S., Wickham, D. J., & Kish, S. J. (2004) · Brain · doi:10.1093/brain/awh046 · Cited by 152 · see citing works

Dyadic Short Forms of the Wechsler Adult Intelligence Scale–III

Ringe, W. K., Saine, K. C., Lacritz, L. H., Hynan, L. S., & Cullum, C. M. (2002) · Assessment · doi:10.1177/1073191102009003004 · Cited by 144 · see citing works

Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss

Harvey, D. C., Laćan, G., Tanious, S. P., & Melega, W. P. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02439-2 · Cited by 127 · see citing works

A new PET ligand for the dopamine transporter: studies in the human brain.

Volkow, N. D., Ding, Y., Fowler, J. S., Wang, G., Logan, J., Gatley, S. J., Schlyer, D. J., & Pappas, N. R. (1995) · PubMed · Cited by 119 · see citing works

Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine

Frey, K. A., Kilbourn, M. R., & Robinson, T. E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01152-7 · Cited by 104 · see citing works

[3H]methoxytetrabenazine: A high specific activity ligand for estimating monoaminergic neuronal integrity

Borght, T. M. V., Sima, A. A. F., Kilbourn, M. R., Desmond, T. J., Kuhl, D. E., & Frey, K. A. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00167-h · Cited by 99 · see citing works

Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study

NORDAHL, T. E., Salo, R. E., Possin, K. L., Gibson, D. R., Flynn, N. M., Leamon, M. H., Galloway, G. P., Pfefferbaum, A., Spielman, D. M., Elfar Adalsteinsson, A., et al. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00088-4 · Cited by 95 · see citing works

Fluorescence histochemistry indicates damage of striatal dopamine nerve terminals in rats after multiple doses of methamphetamine

Lorez, H. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90053-9 · Cited by 93 · see citing works

Equilibrium versus Compartmental Analysis for Assessment of the Vesicular Monoamine Transporter Using (+)-α-[ 11 C]Dihydrotetrabenazine (DTBZ) and Positron Emission Tomography

Koeppe, R. A., Frey, K. A., Kume, A., Albin, R. L., Kilbourn, M. R., & Kuhl, D. E. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199709000-00001 · Cited by 90 · see citing works

Assessment of Extrastriatal Vesicular Monoamine Transporter Binding Site Density Using Stereoisomers of [ 11 C]Dihydrotetrabenazine

Koeppe, R. A., Frey, K. A., Kuhl, D. E., & Kilbourn, M. R. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199912000-00011 · Cited by 77 · see citing works

Highly selective neurotoxins : basic and clinical applications

Kostrzewa, R. M. (1998) · Humana Press eBooks · Cited by 58 · see citing works

Evidence for and Mechanism of Action of Neurotoxicity of Amphetamine Related Compounds

Lew, R., Malberg, J. E., Ricuarte, G. A., & Seiden, L. S. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-477-1_9 · Cited by 25 · see citing works

Analysis of Four Dopaminergic Tracers Kinetics Using Two Different Tissue Input Function Methods

Sossi, V., Holden, J. E., Chan, G. L.-Y., Krzywinski, M. I., Stoessl, A. J., & Ruth, T. J. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200004000-00002 · Cited by 21 · see citing works

The effects of methamphetamine on fine motor control in rhesus monkeys

Johanson, C. E., Aigner, T. G., Seiden, L. S., & Schuster, C. R. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90134-5 · Cited by 16 · see citing works

Effects of dopaminergic agents on eye tracking before and after repeated methamphetamine

Ando, K., Johanson, C. E., & Schuster, C. R. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90576-9 · Cited by 14 · see citing works

Evidence for and Mechanism of Action of Neurotoxicity of Amphetamine Related Compounds

Lew, R., Malberg, J. E., Ricuarte, G. A., & Seiden, L. S. (2003) · Humana Press eBooks · doi:10.1385/0-89603-465-8:235 · Cited by 9 · see citing works

A review of the clinical pharmacology of methamphetamine.

Cruickshank, C., & Dyer, K. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 747 · see citing works

Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis

Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 669 · see citing works

Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature

Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 502 · see citing works

Drug Addiction and the Memory Systems of the Brain

Robbins, T. W., Ersche, K. D., & Everitt, B. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.020 · Cited by 446 · see citing works

Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings

Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432 · see citing works

Structural and metabolic brain changes in the striatum associated with methamphetamine abuse

Chang, L., Alicata, D., Ernst, T. M., & Volkow, N. D. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01782.x · Cited by 431 · see citing works

Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis

Potvin, S., Pelletier, J., Grot, S., Hébert, C., Barr, A. M., & Lecomte, T. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.01.021 · Cited by 359 · see citing works

Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis

Ashok, A. H., Mizuno, Y., Volkow, N. D., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0135 · Cited by 330 · see citing works

Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addictionPreprint

Kutlu, M. G., & Gould, T. J. (2016) · Learning & Memory · doi:10.1101/lm.042192.116 · Cited by 324 · see citing works

Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction

Bickel, W. K., Jarmolowicz, D., Mueller, E. T., Gatchalian, K., & Mcclure, S. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2689-x · Cited by 316 · see citing works

An Evaluation of the Evidence that Methamphetamine Abuse Causes Cognitive Decline in Humans

Dean, A. C., Groman, S. M., Morales, A. M., & London, E. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.179 · Cited by 251 · see citing works

Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical Review

Hart, C. L., Marvin, C. B., Silver, R., & Smith, E. E. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.276 · Cited by 242 · see citing works

Gender differences in methamphetamine use and responses: A review

Dluzen, D. E., & Liu, B. (2008) · Gender Medicine · doi:10.1016/s1550-8579(08)80005-8 · Cited by 232 · see citing works

Neuropathology of substance use disorders

Cadet, J. L., Bisagno, V., & Milroy, C. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1221-7 · Cited by 207 · see citing works

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brašić, J. R., Ye, W., Alexander, M., Dannals, R. F., Wong, D. F., et al. (2007) · Synapse · doi:10.1002/syn.20471 · Cited by 205 · see citing works

In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO

Boileau, I., Payer, D., Chugani, B., Lobo, D. S. S., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., & Zack, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.163 · Cited by 198 · see citing works

Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease

German, C. L., Baladi, M. G., McFadden, L. M., Hanson, G. R., & Fleckenstein, A. E. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010397 · Cited by 195 · see citing works

Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine

Halpin, L. E., Collins, S. A., & Yamamoto, B. K. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.07.014 · Cited by 194 · see citing works

Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging

London, E. D., Kohno, M., Morales, A. M., & Ballard, M. E. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.044 · Cited by 187 · see citing works

Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology

Yu, S., Zhu, L., Shen, Q., Bai, X., & Di, X. (2015) · Behavioural Neurology · doi:10.1155/2015/103969 · Cited by 176 · see citing works

Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity

Trifilieff, P., & Martinez, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.031 · Cited by 171 · see citing works

The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment

Ersche, K. D., & Sahakian, B. J. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9033-y · Cited by 166 · see citing works

High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus

Bowyer, J. F., & Ali, S. F. (2006) · Synapse · doi:10.1002/syn.20324 · Cited by 162 · see citing works

Neurologic Manifestations of Chronic Methamphetamine Abuse

Rusyniak, D. E. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.02.005 · Cited by 162 · see citing works

Neuroimaging for drug addiction and related behaviors

Parvaz, M. A., Alia-Klein, N., Woicik, P. A., Volkow, N. D., & Goldstein, R. Z. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.055 · Cited by 151 · see citing works

Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works

Methamphetamine Self-Administration Is Associated with Persistent Biochemical Alterations in Striatal and Cortical Dopaminergic Terminals in the Rat

Krasnova, I. N., Justinová, Z., Ladenheim, B., Jayanthi, S., McCoy, M. T., Barnes, C., Warner, J. E., Goldberg, S. R., & Cadet, J. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008790 · Cited by 136 · see citing works

Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment

Robertson, C. L., Ishibashi, K., Chudzynski, J. E., Mooney, L. J., Rawson, R. A., Dolezal, B. A., Cooper, C. B., Brown, A. K., Mandelkern, M. A., & London, E. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.331 · Cited by 136 · see citing works

Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment

Moszczyńska, A., & Callan, S. P. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.238501 · Cited by 133 · see citing works

Neurologic Manifestations of Chronic Methamphetamine Abuse

Rusyniak, D. E. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.05.004 · Cited by 125 · see citing works

Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence

Simon, S. L., Dean, A. C., Cordova, X., Monterosso, J. R., & London, E. D. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.335 · Cited by 117 · see citing works

Long-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedrone

den Hollander, B., Rozov, S. V., Linden, A.-M., Uusi‐Oukari, M., Ojanperä, I. A., & Korpi, E. R. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.10.006 · Cited by 113 · see citing works

Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence

Iudicello, J. E., Woods, S. P., Vigil, O., Scott, J. C., Cherner, M., Heaton, R. K., Atkinson, J. H., Grant, I., & Ce, T. H. N. R. (2010) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903512637 · Cited by 111 · see citing works

Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches

Cadet, J. L., & Bisagno, V. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00189 · Cited by 110 · see citing works

Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors

Shin, E., Dang, D., Tran, T.-V., Tran, H., Jeong, J. H., Nah, S.-Y., Jang, C., Yamada, K., Nabeshima, T., & Kim, H. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0897-y · Cited by 104 · see citing works

Pharmacotherapeutic agents in the treatment of methamphetamine dependence

Morley, K. C., Cornish, J. L., Faingold, A., Wood, K., & Haber, P. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1313229 · Cited by 108 · see citing works

Substance use disorders in individuals with mild to borderline intellectual disability: Current status and future directions

van Duijvenbode, N., VanDerNagel, J., Didden, R., Engels, R. C. M. E., Buitelaar, J. K., Kiewik, M., & de Jong, C. A. J. (2015) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.12.029 · Cited by 104 · see citing works

A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction

Galloway, G., Buscemi, R., Coyle, J., Flower, K., Siegrist, J. D., Fiske, L. A., Baggott, M. J., Li, L., Polcin, D. L., Chen, C. A., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.307 · Cited by 103 · see citing works

Neurocognitive deficits are associated with unemployment in chronic methamphetamine users

Weber, E., Blackstone, K., Iudicello, J., Morgan, E. E., Grant, I., Moore, D. J., & Woods, S. P. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.04.002 · Cited by 102 · see citing works

Genetically Determined Interaction between the Dopamine Transporter and the D2Receptor on Prefronto-Striatal Activity and Volume in Humans

Bertolino, A., Fazio, L., Giorgio, A. D., Blasi, G., Romano, R., Taurisano, P., Caforio, G., Sinibaldi, L., Ursini, G., Popolizio, T., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4858-08.2009 · Cited by 101 · see citing works

Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications

Fleckenstein, A. E., Volz, T. J., & Hanson, G. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.002 · Cited by 100 · see citing works

Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker?

Boileau, I., Rusjan, P., Houle, S., Wilkins, D., Tong, J., Selby, P., Guttman, M., Saint-Cyr, J. A., Wilson, A. A., & Kish, S. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3008-08.2008 · Cited by 100 · see citing works

Effect of methamphetamine dependence on everyday functional ability

Henry, B. L., Minassian, A., & Perry, W. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.01.013 · Cited by 96 · see citing works

Enduring Deficits in Sustained Visual Attention during Withdrawal of Intravenous Methylenedioxymethamphetamine Self-Administration in Rats: Results from a Comparative Study with d-Amphetamine and Methamphetamine

Dalley, J. W., Lääne, K., Theobald, D. E. H., Peña-López, Y., Bruce, C. C., Huszar, A. C., Wojcieszek, M., Everitt, B. J., & Robbins, T. W. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301220 · Cited by 89 · see citing works

Brain serotonin transporter in human methamphetamine users

Kish, S. J., Fitzmaurice, P. S., Boileau, I., Schmunk, G. A., Ang, L.-C., Furukawa, Y., Chang, L., Wickham, D. J., Sherwin, A. L., & Tong, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1346-x · Cited by 93 · see citing works

Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use

Aron, J. L., & Paulus, M. P. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01778.x · Cited by 91 · see citing works

Levels of 4-Hydroxynonenal and Malondialdehyde Are Increased in Brain of Human Chronic Users of Methamphetamine

Fitzmaurice, P. S., Tong, J., Yazdanpanah, M., Liu, P. P., Kalasinsky, K. S., & Kish, S. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109173 · Cited by 89 · see citing works

Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine

Harro, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.004 · Cited by 84 · see citing works

Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway

Hedges, D. M., Obray, J. D., Yorgason, J. T., Jang, E. Y., Weeresekara, V., Uys, J. D. K., Bellinger, F. P., & Steffensen, S. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.291 · Cited by 81 · see citing works

Long-Term Methamphetamine Administration in the Vervet Monkey Models Aspects of a Human Exposure: Brain Neurotoxicity and Behavioral Profiles

Melega, W. P., Jorgensen, M. J., Laćan, G., Way, B. M., Pham, J., Morton, G. G., Cho, A. K., & Fairbanks, L. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301502 · Cited by 78 · see citing works

The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans

Olive, M. F., Taylor, & Lewis (2013) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s39684 · Cited by 78 · see citing works

The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction

Sambo, D. O., Lebowitz, J. J., & Khoshbouei, H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.009 · Cited by 75 · see citing works

Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults

Cherner, M., Suárez, P., Casey, C. Y., Deiss, R., Letendre, S. L., Marcotte, T. D., Vaida, F., Atkinson, J. H., Grant, I., & Heaton, R. K. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.08.010 · Cited by 76 · see citing works

A placebo‐controlled trial of mirtazapine for the management of methamphetamine withdrawal

CRUICKSHANK, C. C., MONTEBELLO, M. E., DYER, K. R., QUIGLEY, A., BLASZCZYK, J., TOMKINS, S., & SHAND, D. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801935672 · Cited by 74 · see citing works

Imaging studies on dopamine transporter and depression: A review of literature and suggestions for future research

Camardese, G., Giuda, D. D., Nicola, M. D., Cocciolillo, F., Giordano, A., Janiri, L., & Guglielmo, R. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.12.006 · Cited by 72 · see citing works

Methamphetamine abuse disturbs the dopaminergic system to impair hippocampal-based learning and memory: An overview of animal and human investigations

Shukla, M., & Vincent, B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.016 · Cited by 72 · see citing works

Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects

Rampino, A., Marakhovskaia, A., Soares-Silva, T., Torretta, S., Veneziani, F., & Beaulieu, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00702 · Cited by 70 · see citing works

Neuropsychological deficits in adolescent methamphetamine abusers

King, G., Alicata, D., Cloak, C. C., & Chang, L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1949-x · Cited by 70 · see citing works

Mitochondria: key players in the neurotoxic effects of amphetamines

Barbosa, D. J., Capela, J. P., Feio‐Azevedo, R., Gomes, A., Bastos, M. D. L., & Carvalho, F. D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1478-9 · Cited by 69 · see citing works

Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure

McFadden, L. M., Hadlock, G. C., Allen, S. C., Vieira‐Brock, P. L., Stout, K. A., Ellis, J. D., Hoonakker, A. J., Andrenyak, D. M., Nielsen, S. M., Wilkins, D. G., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188433 · Cited by 67 · see citing works

Brain dopamine neurone ‘damage’: methamphetamine users vs. Parkinson's disease – a critical assessment of the evidence

Kish, S. J., Boileau, I., Callaghan, R. C., & Tong, J. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13363 · Cited by 67 · see citing works

Cocaine Abuse in Humans Is Not Associated with Increased Microglial Activation: An 18-kDa Translocator Protein Positron Emission Tomography Imaging Study with [11C]PBR28

Narendran, R., Lopresti, B. J., Mason, N. S., Deuitch, L., Paris, J., Himes, M. L., Kodavali, C. V., & Nimgaonkar, V. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0928-14.2014 · Cited by 66 · see citing works

Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers

Newton, T. F., Reid, M. S., Garza, R. D. L., Mahoney, J. J., Abad, A., Condos, R., Palamar, J. J., Halkitis, P. N., Mojisak, J., Anderson, A., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009097 · Cited by 61 · see citing works

Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits

Bisagno, V., González, B., & Urbano, F. J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.013 · Cited by 59 · see citing works

Ammonia Mediates Methamphetamine-Induced Increases in Glutamate and Excitotoxicity

Halpin, L. E., Northrop, N. A., & Yamamoto, B. K. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.306 · Cited by 57 · see citing works

Withdrawal from chronic treatment with methamphetamine induces anxiety and depression-like behavior in mice

Ru, Q., Xiong, Q., Zhou, M., Chen, L., Tian, X., Xiao, H., Li, Z., & Li, Y. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.11.072 · Cited by 57 · see citing works

Monoamine Transporter Inhibitors and Substrates as Treatments for Stimulant Abuse

Howell, L. L., & Negus, S. S. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00004-4 · Cited by 56 · see citing works

Striatal Volume Increases in Active Methamphetamine-Dependent Individuals and Correlation with Cognitive Performance

Jan, R. K., Lin, J. C., Miles, S. W., Kydd, R. R., & Russell, B. (2012) · Brain Sciences · doi:10.3390/brainsci2040553 · Cited by 56 · see citing works

8.3 Imaging Dopamine’s Role in Drug Abuse and Addiction

Volkow, N. D., Fowler, J. S., Wang, G., Telang, F., & Baler, R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0028 · Cited by 58 · see citing works

In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers

Narendran, R., Lopresti, B. J., Martinez, D., Mason, N. S., Himes, M., May, M. A., Daley, D. C., Price, J. C., Mathis, C. A., & Frankle, W. G. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010126 · Cited by 53 · see citing works

Abnormal Striatal Circuitry and Intensified Novelty Seeking among Adolescents Who Abuse Methamphetamine and Cannabis

Churchwell, J. C., Carey, P. D., Ferrett, H. L., Stein, D. J., & Yurgelun-Todd, D. A. (2012) · Developmental Neuroscience · doi:10.1159/000337724 · Cited by 52 · see citing works

Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies

Proebstl, L., Kamp, F., Manz, K., Krause, D., Adorjan, K., Pogarell, O., Koller, G., Soyka, M., Falkai, P., & Kambeitz, J. (2019) · European psychiatry · doi:10.1016/j.eurpsy.2019.03.003 · Cited by 52 · see citing works

Role of microglia in methamphetamine-induced neurotoxicity.

Xu, E., Liu, J., Liu, H., Wang, X., & Xiong, H. (2017) · Europe PMC (PubMed Central) · Cited by 52 · see citing works

Functional and Structural Brain Changes Associated with Methamphetamine Abuse

Jan, R. K., Kydd, R. R., & Russell, B. R. (2012) · Brain Sciences · doi:10.3390/brainsci2040434 · Cited by 51 · see citing works

Compulsivity Across the Pathological Misuse of Drug and Non-Drug Rewards

Banca, P., Harrison, N. A., & Voon, V. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00154 · Cited by 52 · see citing works

Assessment of Executive Functions in Methamphetamineaddicted Individuals: Emphasis on Duration of Addiction and Abstinence

Farhadian, M., Akbarfahimi, M., Hassani‐Abharian, P., Hosseini, S. G., & Shokri, S. (2017) · Basic and Clinical Neuroscience Journal · doi:10.18869/nirp.bcn.8.2.147 · Cited by 51 · see citing works

Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research

Guerin, A. A., Bonomo, Y. A., Lawrence, A. J., Baune, B. T., Nestler, E. J., Rossell, S. L., & Kim, J. H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00880 · Cited by 48 · see citing works

Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana

Sung, Y., Carey, P. D., Stein, D. J., Ferrett, H. L., Spottiswoode, B. S., Renshaw, P. F., & Yurgelun-Todd, D. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.028 · Cited by 45 · see citing works

Translatable and Back-Translatable Measurement of Impulsivity and Compulsivity: Convergent and Divergent Processes

Voon, V., & Dalley, J. W. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5013 · Cited by 46 · see citing works

Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials

Acheson, L. S., Williams, B. H., Farrell, M., McKetin, R., Ezard, N., & Siefried, K. J. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13511 · Cited by 45 · see citing works

Striatal dopamine D1 and D2 receptors: Widespread influences on methamphetamine‐induced dopamine and serotonin neurotoxicity

Gross, N. B., Duncker, P. C., & Marshall, J. F. (2011) · Synapse · doi:10.1002/syn.20952 · Cited by 44 · see citing works

Dopamine modulating drugs influence striatal (+)‐[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration

Tong, J., Wilson, A. A., Boileau, I., Houle, S., & Kish, S. J. (2008) · Synapse · doi:10.1002/syn.20573 · Cited by 44 · see citing works

A Single Neurotoxic Dose of Methamphetamine Induces a Long-Lasting Depressive-Like Behaviour in Mice

Silva, C., Neves, A. F., Dias, A. I., de Freitas, H. J. F., Mendes, S. M., Pita, I. R., Viana, S., de Oliveira, P. A., Cunha, R. A., Ribeiro, C., et al. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9423-2 · Cited by 43 · see citing works

Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice

Grace, C. E., Schaefer, T. L., Herring, N. R., Graham, D. L., Skelton, M. R., Gudelsky, G. A., Williams, M. T., & Vorhees, C. V. (2010) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2010.01.006 · Cited by 42 · see citing works

Environmental enrichment reduces methamphetamine cue-induced reinstatement but does not alter methamphetamine reward or VMAT2 function

Hofford, R. S., Darna, M., Wilmouth, C. E., Dwoskin, L. P., & Bardo, M. T. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.007 · Cited by 42 · see citing works

A neurotoxic regimen of methamphetamine impairs novelty recognition as measured by a social odor-based task

O’Dell, S. J., Feinberg, L. M., & Marshall, J. F. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.022 · Cited by 41 · see citing works

Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling

London, E. D. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.002 · Cited by 40 · see citing works

A meta-analysis of the relationship between abstinence and neuropsychological functioning in methamphetamine use disorder.

Basterfield, C., Hester, R., & Bowden, S. C. (2019) · Neuropsychology · doi:10.1037/neu0000552 · Cited by 43 · see citing works

Methamphetamine Preconditioning: Differential Protective Effects on Monoaminergic Systems in the Rat Brain

Cadet, J. L., Krasnova, I. N., Ladenheim, B., Cai, N.-S., McCoy, M. T., & Atianjoh, F. E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9026-0 · Cited by 40 · see citing works

Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior

Saloner, R., Fields, J. A., Marcondes, M. C. G., Iudicello, J. E., von Känel, S., Cherner, M., Letendre, S. L., Kaul, M., & Grant, I. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09957-0 · Cited by 38 · see citing works

Biological substrates of addiction

Joffe, M. E., Grueter, C. A., & Grueter, B. A. (2014) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1273 · Cited by 39 · see citing works

Pattern and related factors of cognitive impairment among chronic methamphetamine users

Wang, T., Fan, T., Bao, Y., Li, X.-D., Liang, C., Wang, R., Ma, J., Han, Y., Meng, S., Wu, P., et al. (2017) · American Journal on Addictions · doi:10.1111/ajad.12505 · Cited by 39 · see citing works

Decreased cortical complexity in methamphetamine abusers

Yun, K., Park, H.-K., Kwon, D.-H., Kim, Y., Cho, S., Cho, H.-J., Peterson, B. S., & Jeong, J. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.07.009 · Cited by 38 · see citing works

Working Memory and Speed of Information Processing in Chronic Khat Users: Preliminary Findings

Hoffman, R., & Al’Absi, M. (2012) · European Addiction Research · doi:10.1159/000338285 · Cited by 38 · see citing works

Neurologic Complications of Psychomotor Stimulant Abuse

Sanchez‐Ramos, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.003 · Cited by 39 · see citing works

Aripiprazole as a potential pharmacotherapy for stimulant dependence: Human laboratory studies with d-amphetamine.

Stoops, W. W. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.4.413 · Cited by 38 · see citing works

Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal

Ren, W., Luan, X., Zhang, J., Gutteea, P., Cai, Y., Zhao, J., Gu, Y., Wu, C., Su, H., Tao, J., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.017 · Cited by 37 · see citing works

Neuropsychological comparisons of cocaine versus methamphetamine users: A research synthesis and meta-analysis

Hall, M. G., Hauson, A. O., Wollman, S. C., Allen, K. E., Connors, E. J., Stern, M. J., Kimmel, C. L., Stephan, R. A., Sarkissians, S., Barlet, B. D., et al. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1355919 · Cited by 37 · see citing works

Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls

Wang, L., Chen, C., Lin, S., Chen, Y., Xu, K., & Huang, M. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4910-z · Cited by 37 · see citing works

Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons

Graves, S. M., Schwarzschild, S. E., Tai, R., Chen, Y., & Surmeier, D. J. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105409 · Cited by 37 · see citing works

Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brašić, J. R., Ye, W., Alexander, M., Dannals, R. F., Wong, D. F., et al. (2007) · Synapse · doi:10.1002/syn.20471 · Cited by 205 · see citing works

Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: a SPECT study

Chou, Y.-H., Huang, W.-S., Su, T.-P., Lu, R.-B., Wan, F.-J., & Fu, Y.-K. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.05.002 · Cited by 78 · see citing works

Medical and

Volkow, N. D., Chang, L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., HITZEMANN, R. J., Yushin, D., et al. (2013)

Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence

Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Miller, E. N., HITZEMANN, R. J., Ding, Y., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754 · see citing works

Volume contents

(2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00194-6